Basal cell carcinoma secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Basal cell carcinoma}}
{{Basal cell carcinoma}}
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.,{{M.N}}


==Overview==
==Overview==
Line 16: Line 16:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Disease]]
{{WH}}
[[Category:Dermatology]]
{{WS}}
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Pathology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Surgery]]
[[Category:Surgery]]

Latest revision as of 15:24, 6 March 2019

Basal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Basal Cell Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Basal cell carcinoma secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Basal cell carcinoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Basal cell carcinoma secondary prevention

CDC on Basal cell carcinoma secondary prevention

Basal cell carcinoma secondary prevention in the news

Blogs on Basal cell carcinoma secondary prevention

Directions to Hospitals Treating Basal cell carcinoma

Risk calculators and risk factors for Basal cell carcinoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D., Maneesha Nandimandalam, M.B.B.S.[2]

Overview

A skin biopsy and chemotherapeutic agents such as 5-Fluorouracil or Imiquimod may prevent the further development of basal cell carcinoma.

Basal Cell Carcinoma Secondary Prevention

References

  1. Linos E, Katz KA, Colditz GA (October 2016). "Skin Cancer-The Importance of Prevention". JAMA Intern Med. 176 (10): 1435–1436. doi:10.1001/jamainternmed.2016.5008. PMC 5489348. PMID 27459394.
  2. Koh, Howard K.; Geller, Alan C. (2004). "Skin cancer prevention comes of age". American Journal of Preventive Medicine. 27 (5): 484–485. doi:10.1016/j.amepre.2004.08.011. ISSN 0749-3797.

Template:WH Template:WS